company | |
Industry | Advertising |
---|---|
Founded | 2004 |
Headquarters | United States of America |
2,132 Followers, 17 Following, 0 Posts - See Instagram photos and videos from Anomaly (@anomalyautism). December Dec 9, 1994 ( age 25) Most Popular #5554. Born on December 9 #14. Born in Sweden #19. Web Star Born in Sweden #10. Gamer and superstar on YouTube and Twitch whose most watched content on the former network features gameplay from Counter-Strike: Global Offensive. His numbers include more than 2.7 million subscribers on YouTube and 1.2.
Anomaly is an advertising agency founded in 2004 in New York City. The agency has offices in Los Angeles, New York, Toronto, London, Amsterdam, Berlin, and Shanghai.[1][2]
The agency was founded by Carl Johnson, Jason Deland, Johnny Vulkan, Mike Byrne, Richard Mulder, and Justin Barocas.[3]
Anomaly's clients have included Ally,[4]Anheuser-Busch InBev, Beats,[5] The Campbell Soup Company, Converse, Diageo, Dick's Sporting Goods, Diesel, Google, The Hershey Company, Kohl's, Major League Baseball, MINI Canada (a division of BMW),[6]New York Life Insurance, Panera Bread, Petco,[7] and Sally Hansen.[8]
Additionally, Anomaly has holdings in companies such as hmbldt,[9] Avec Eric, EOS,[10] Mighty Jaxx[11] and The Unreasonable.[12]
Anomaly was named Advertising Age's 2017 Agency of the Year [13] and was also distinguished as a Creativity Innovator.[14] Martin heidegger was ist metaphysik pdf reader.
Anomaly was #24 in a Fast Company article titled 'The World's Most Innovative Companies';[15] and mentioned in Ad Age magazine (#4 in 2016 'Agency A-List' report,[16] #7 in 2015 'Agency A-List' report.[17])
Anomaly won 'Brand of the Year' at the Designer Toy Awards for the agency's Mighty Jaxx venture.[18][failed verification] Anomaly has won Gold Media Effies for Converse and 'Keep a Child Alive' Foundation.[19]
Ebstein's anomaly | |
---|---|
Pathological specimen and ultrasound image of a heart with Ebstein's anomaly: Abbreviations: RA: right atrium; ARV: atrialized right ventricle; FRV: functional right ventricle; AL: anterior leaflet; SL: septal leaflet; LA: left atrium; LV: left ventricle; asterisk: grade II tethering of the tricuspid septal leaflet | |
Specialty | Cardiology |
Ebstein's anomaly is a congenital heart defect in which the septal and posterior leaflets of the tricuspid valve are displaced towards the apex of the right ventricle of the heart. It is classified as a critical congenital heart defect[1] accounting for <1% of all congenital heart defects presenting in ≈1 per 200,000 live births.[2]
The annulus of the valve is still in the normal position. The valve leaflets, however, are to a varying degree, attached to the walls and septum of the right ventricle. A subsequent 'atrialization' of a portion of the morphologic right ventricle (which is then contiguous with the right atrium) is seen. This causes the right atrium to be large and the anatomic right ventricle to be small in size.
While Ebstein's anomaly is defined as the congenital displacement of the tricuspid valve towards the apex of the right ventricle, it is often associated with other abnormalities.
Typically, anatomic abnormalities of the tricuspid valve exist, with enlargement of the anterior leaflet of the valve. The other leaflets are described as being plastered to the endocardium.
About 50% of individuals with Ebstein's anomaly have an associated shunt between the right and left atria, either an atrial septal defect or a patent foramen ovale.[3]
About 50% of individuals with Ebstein's anomaly have an accessory pathway with evidence of Wolff-Parkinson-White syndrome, secondary to the atrialized right ventricular tissue. This can lead to abnormal heart rhythms including atrioventricular re-entrant tachycardia.
Other abnormalities that can be seen on the ECG include:
An enlargement of the aorta may occur; an increased risk of abnormality is seen in babies of women taking lithium during the first trimester of pregnancy[5] (though some have questioned this)[6] and in those with Wolff-Parkinson-White syndrome.
Ebstein's cardiophysiology typically presents as an (antidromic) AV reentrant tachycardia with associated pre-excitation. In this setting, the preferred medication treatment agent is procainamide. Since AV-blockade may promote conduction over the accessory pathway, drugs such as beta blockers, calcium channel blockers, and digoxin are contraindicated.
If atrial fibrillation with pre-excitation occurs, treatment options include procainamide, flecainide, propafenone, dofetilide, and ibutilide, since these medications slow conduction in the accessory pathway causing the tachycardia and should be administered before considering electrical cardioversion. Intravenous amiodarone may also convert atrial fibrillation and/or slow the ventricular response.
The Canadian Cardiovascular Society (CCS) recommends surgical intervention for these indications:[7]
The CCS further recommends patients who require operation for Ebstein's anomaly should be operated on by congenital heart surgeons who have substantial specific experience and success with this operation. Every effort should be made to preserve the native tricuspid valve.[7]
Ebstein's anomaly was named after Wilhelm Ebstein,[8][9] who in 1866 described the heart of the 19-year-old Joseph Prescher.
Classification |
|
---|---|
External resources |
Wikimedia Commons has media related to Ebstein's anomaly. |